series-c-plus
Stage
3
Investors
About
Aleva Neurotherapeutics designs and manufactures directional deep brain stimulation systems, including the directSTIM™ system with a 24-contact directional lead and MICC generator, to treat Parkinson’s disease and essential tremor, and provides clinical training and support to healthcare professionals.
Explore Aleva Neurotherapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.